Raymond James Financial Inc. Invests $77.94 Million in Encompass Health Co. (NYSE:EHC)

Raymond James Financial Inc. purchased a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 844,006 shares of the company's stock, valued at approximately $77,944,000. Raymond James Financial Inc. owned 0.84% of Encompass Health as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in Encompass Health in the 3rd quarter valued at approximately $40,000. Tompkins Financial Corp purchased a new position in shares of Encompass Health during the fourth quarter worth $46,000. V Square Quantitative Management LLC lifted its position in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health in the third quarter worth $68,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. KeyCorp increased their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Barclays upped their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Ten investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $107.67.

Remove Ads

Encompass Health Stock Down 0.7 %

NYSE:EHC traded down $0.71 during trading hours on Thursday, hitting $93.57. 836,482 shares of the stock traded hands, compared to its average volume of 637,145. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a fifty-two week low of $74.27 and a fifty-two week high of $104.55. The firm has a 50 day moving average price of $97.22 and a 200 day moving average price of $96.88. The firm has a market cap of $9.42 billion, a price-to-earnings ratio of 20.98, a PEG ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.73%. The ex-dividend date is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.10% of the stock is owned by corporate insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.